- The Stability of the Anti-Mullerian Hormone in Serum and Plasma Samples under Various Preanalytical Conditions2023 | Lékařská fakulta v Plzni
- AMH levels and IVF stimulation2013 | 1. lékařská fakulta, Fakulta tělesné výchovy a sportu, 2. lékařská fakulta
- HE4 and other markers in ovarian cancer2013 | Publikace bez příslušnosti k fakultě
- The role of AMH in the egg donation program2013 | 1. lékařská fakulta, Fakulta tělesn é výchovy a sportu, 2. lékařská fakulta
- Antimülleriánský hormon - jeho využití v klinické praxi a budoucí možnosti2023 | 1. lékařská fakulta
- Effect of long-term using of hormonal contraception on anti-Müllerian hormone secretion2016 | Lékařská fakulta v Plzni
- Anti-Müllerian hormone in serum and seminal plasma in comparison with other male fertility parameters2016 | Lékařská fakulta v Plzni
- Ovarian response to 150 mu g corifollitropin alfa in a GnRH-antagonist multiple-dose protocol: a prospective cohort study2017 | 2. lékařská fakulta
- Follicular fluid levels of anti-Mullerian hormone, insulin-like growth factor 1 and leptin in women with fertility disorders2018 | Lékařská fakulta v Plzni
- Genetic variation in gonadal impairment in female survivors of childhood cancer: a PanCareLIFE study protocol2018 | 2. lékařská fakulta
- Effect of genetic variation in CYP450 on Gonadal impairment in a European cohort of female childhood cancer survivors, based on a candidate gene approach: Results from the pancareLIFE study2021 | 2. lékařská fakulta
- Treatment-related fertility impairment in long-term female childhood, adolescent and young adult cancer survivors: investigating dose-effect relationships in a European case-control study (PanCareLIFE)2021 | 2. lékařská fakulta
- Possible modification of BRSK1 on the risk of alkylating chemotherapy-related reduced ovarian function2021 | 2. lékařská fakulta